Related Experiment Video
Updated: May 26, 2026

08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
Finally, a transgenic light chain amyloidosis mouse model.
1The Scripps Research Institute.
Blood
|December 17, 2011
Summary
Researchers developed the first transgenic mouse model for light chain amyloidosis. This new model effectively aids in evaluating potential pharmaceutical treatments for the condition.
Area of Science:
- Biomedical research
- Genetics
- Pharmacology
Background:
- Light chain amyloidosis is a serious plasma cell disorder.
- Current treatment options are limited and often insufficient.
- A need exists for better preclinical models to accelerate drug development.
More Related Videos
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019